Cargando…

Correction to: Inhibition of p53 and/or AKT as a new therapeutic approach specifically targeting ALT cancers

Detalles Bibliográficos
Autores principales:	Ge, Yuanlong, Wu, Shu, Zhang, Zepeng, Li, Xiaocui, Li, Feng, Yan, Siyu, Liu, Haiying, Huang, Junjiu, Zhao, Yong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Higher Education Press 2019
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6881410/ https://www.ncbi.nlm.nih.gov/pubmed/31187422 http://dx.doi.org/10.1007/s13238-019-0640-1

Ejemplares similares

Inhibition of p53 and/or AKT as a new therapeutic approach specifically targeting ALT cancers
por: Ge, Yuanlong, et al.
Publicado: (2019)

BRM-SWI/SNF chromatin remodeling complex enables functional telomeres by promoting co-expression of TRF2 and TRF1
por: Wu, Shu, et al.
Publicado: (2020)

Correction: p53 and metabolism: from mechanism to therapeutics
por: Simabuco, Fernando M., et al.
Publicado: (2018)

Preferential extension of short telomeres induced by low extracellular pH
por: Ge, Yuanlong, et al.
Publicado: (2016)

Nuclear envelope tethering inhibits the formation of ALT-associated PML bodies in ALT cells
por: Yang, Chia-Wei, et al.
Publicado: (2021)

Switch telomerase to ALT mechanism by inducing telomeric DNA damages and dysfunction of ATRX and DAXX
por: Hu, Yang, et al.
Publicado: (2016)

Author Correction: MDM4 inhibition: a novel therapeutic strategy to reactivate p53 in hepatoblastoma
por: Woodfield, Sarah E., et al.
Publicado: (2021)

A critical role of telomere chromatin compaction in ALT tumor cell growth
por: Shi, Guang, et al.
Publicado: (2020)

Author Correction: The FANCM-BLM-TOP3A-RMI complex suppresses alternative lengthening of telomeres (ALT)
por: Lu, Robert, et al.
Publicado: (2019)

Author Correction: TERRA transcription destabilizes telomere integrity to initiate break-induced replication in human ALT cells
por: Silva, Bruno, et al.
Publicado: (2023)

ALT cancer cells are specifically sensitive to lysine acetyl transferase inhibition
por: Bakhos-Douaihy, Dalal, et al.
Publicado: (2019)

Strand break-induced replication fork collapse leads to C-circles, C-overhangs and telomeric recombination
por: Zhang, Tianpeng, et al.
Publicado: (2019)

Correction: Cancer therapeutic approach based on conformational stabilization of mutant p53 protein by small peptides
por: Tal, Perry, et al.
Publicado: (2019)

Correction: CELLFOOD™ induces apoptosis in human mesothelioma and colorectal cancer cells by modulating p53, c-myc and pAkt signaling pathways
por: Nuvoli, Barbara, et al.
Publicado: (2022)

Correction to: IGFBP7 inhibits cell proliferation by suppressing AKT activity and cell cycle progression in thyroid carcinoma
por: Zhang, Le, et al.
Publicado: (2019)

Correction to: The TRIM protein Mitsugumin 53 enhances survival and therapeutic efficacy of stem cells in murine traumatic brain injury
por: Guan, Fangxia, et al.
Publicado: (2021)

Correction: PID1 alters the antilipolytic action of insulin and increases lipolysis via inhibition of AKT/PKA pathway activation
por: Yin, Chunyan, et al.
Publicado: (2019)

Correction: SETD2 loss sensitizes cells to PI3Kβ and AKT inhibition
por: Terzo, Esteban A., et al.
Publicado: (2019)

Correction: Akt and c-Myc Induce Stem-Cell Markers in Mature Primary p53(−/−) Astrocytes and Render These Cells Gliomagenic in the Brain of Immunocompetent Mice
por: Radke, Josefine, et al.
Publicado: (2013)

Correction: Implications of PI3K/AKT inhibition on REST protein stability and neuroendocrine phenotype acquisition in prostate cancer cells
por: Chen, Ruiqi, et al.
Publicado: (2018)

Correction to: MIIP inhibits the growth of prostate cancer via interaction with PP1α and negative modulation of AKT signaling
por: Yan, Guang, et al.
Publicado: (2019)

Correction: CDKL3 promotes osteosarcoma progression by activating Akt/PKB
por: He, Aina, et al.
Publicado: (2022)

Correction: HDAC Inhibition Elicits Myocardial Protective Effect through Modulation of MKK3/Akt-1
por: Zhao, Ting C., et al.
Publicado: (2013)

Correction: MicroRNA-302a Suppresses Tumor Cell Proliferation by Inhibiting AKT in Prostate Cancer
Publicado: (2020)

Correction: Mechanical Stretch Inhibits MicroRNA499 via p53 to Regulate Calcineurin-A Expression in Rat Cardiomyocytes
por: Chual, Su-Kiat, et al.
Publicado: (2016)

Correction: Akt: a key transducer in cancer
por: Tsai, Pei-Jane, et al.
Publicado: (2023)

Correction to: M2 macrophage-derived exosomal microRNAs inhibit cell migration and invasion in gliomas through PI3K/AKT/mTOR signaling pathway
por: Yao, Jie, et al.
Publicado: (2021)

Correction to: Flavagline analog FL3 induces cell cycle arrest in urothelial carcinoma cell of the bladder by inhibiting the Akt/PHB interaction to activate the GADD45α pathway
por: Yuan, Gangjun, et al.
Publicado: (2021)

Correction: Flavagline analog FL3 induces cell cycle arrest in urothelial carcinoma cell of the bladder by inhibiting the Akt/PHB interaction to activate the GADD45α pathway
por: Yuan, Gangjun, et al.
Publicado: (2022)

Correction to: Oroxylin A promotes PTEN-mediated negative regulation of MDM2 transcription via SIRT3-mediated deacetylation to stabilize p53 and inhibit glycolysis in wt-p53 cancer cells
por: Zhao, Kai, et al.
Publicado: (2019)

Correction to Lancet Neurol 2018; 17: 939–53
Publicado: (2021)

Correction: Polyphyllin II inhibits liver cancer cell proliferation, migration and invasion through downregulated cofilin activity and the AKT/NF-κB pathway
por: Pang, Dejiang, et al.
Publicado: (2023)

Correction: Resveratrol reverses Doxorubicin resistance by inhibiting epithelial-mesenchymal transition (EMT) through modulating PTEN/ Akt signaling pathway in gastric cancer
por: Xu, Jiahui, et al.
Publicado: (2023)

Correction: Artocarpin, an isoprenyl flavonoid, induces p53-dependent or independent apoptosis via ROS-mediated MAPKs and Akt activation in non-small cell lung cancer cells
por: Tsai, Ming-Horng, et al.
Publicado: (2019)

Correction: The role of AKT and FOXO3 in preventing ovarian toxicity induced by cyclophosphamide
por: Zhang, Bao-fang, et al.
Publicado: (2019)

Correction: Protective role of p53 in skin cancer: Carcinogenesis studies in mice lacking epidermal p53
por: Page, Angustias, et al.
Publicado: (2017)

Correction to Lancet Diabetes Endocrinol 2015; 3: 243–53
Publicado: (2015)

Author Correction: Alpha-fetoprotein inhibits autophagy to promote malignant behaviour in hepatocellular carcinoma cells by activating PI3K/AKT/mTOR signalling
por: Wang, Shanshan, et al.
Publicado: (2019)

Publisher Correction: Alpha-fetoprotein inhibits autophagy to promote malignant behaviour in hepatocellular carcinoma cells by activating PI3K/AKT/mTOR signalling
por: Wang, Shanshan, et al.
Publicado: (2019)

TIN2 deficiency leads to ALT-associated phenotypes and differentiation defects in embryonic stem cells
por: Yin, Shanshan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_eppk5qcu5l93hid9lmejtjnem6